Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study
Open Access
- 15 April 2012
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 68 (11), 1533-1540
- https://doi.org/10.1007/s00228-012-1283-9
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are known to antagonize the effects of antihypertensive drugs, and these associations can lead to an increase in arterial blood pressure. However, the impact of NSAIDs on hypertension treatment management in large-scale populations remains poorly evaluated. We examined whether the introduction of NSAID into the treatment regimen would induce an intensification of hypertension treatment (defined as the introduction of a new antihypertensive drug). We conducted a cohort study involving 5,710 hypertensive subjects included in the French health insurance system database who had been treated and stabilized with their antihypertensive therapy and not exposed to any NSAID between 1 April 2005 and 1 April 2006. The maximum follow-up duration was 4 years. Adjusted hazard ratios (HR) for hypertension treatment intensification were 1.34 [95 % confidence interval (CI) 1.05–1.71] for NSAIDs in general, 1.79 (95 % CI 1.15–2.78) for diclofenac and 2.02 (95 % CI:1.09–3.77) for piroxicam. There were significant interactions between NSAIDs and angiotensin converting enzyme inhibitors (ACEIs; HR 4.09, 95 % CI 2.02–8.27) or angiotensin receptor blockers (ARBs; HR 3.62, 95 % CI 1.80–7.31), but not with other antihypertensive drugs. Exposure to NSAIDs leads to an intensification of hypertension treatment, especially in patients treated with ACEIs or ARBs. Renin–angiotensin system blockers should be avoided whenever NSAIDs are prescribed.Keywords
This publication has 32 references indexed in Scilit:
- Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational StudiesPLoS Medicine, 2011
- Acetaminophen Increases Blood Pressure in Patients With Coronary Artery DiseaseCell Metabolism, 2010
- Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran communityBritish Journal of Clinical Pharmacology, 2010
- Intensifying Therapy for Hypertension Despite Suboptimal AdherenceHypertension, 2009
- The CADEUS study: burden of nonsteroidal anti‐inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workersBritish Journal of Clinical Pharmacology, 2008
- The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million peoplePharmacoepidemiology and Drug Safety, 2008
- Failure to Intensify Antihypertensive Treatment by Primary Care Providers: A Cohort Study in Adults with Diabetes Mellitus and HypertensionJournal of General Internal Medicine, 2008
- Action or Inaction? Decision Making in Patients With Diabetes and Elevated Blood Pressure in Primary CareDiabetes Care, 2006
- Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritisThe American Journal of Cardiology, 2002
- Pharmacokinetics of Oxicam Nonsteroidal Anti-Inflammatory AgentsClinical Pharmacokinetics, 1994